Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model.

Panda H, Keleku-Lukwete N, Kuga A, Fuke N, Suganuma H, Suzuki M, Yamamoto M.

Exp Hematol. 2019 Sep;77:51-60.e1. doi: 10.1016/j.exphem.2019.08.001. Epub 2019 Aug 9.

2.

Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme.

Ueda K, Ye W, Lombard L, Kuga A, Kim Y, Cotton S, Jackson J, Treuer T.

J Headache Pain. 2019 Jun 7;20(1):68. doi: 10.1186/s10194-019-1012-1.

3.

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy.

Kuga A, Otsubo T, Tsuji T, Hayashi S, Imagawa H, Fujikoshi S, Escobar R.

Neuropsychiatr Dis Treat. 2019 Apr 5;15:809-817. doi: 10.2147/NDT.S195445. eCollection 2019.

4.

Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study.

Harada E, Satoi Y, Kuga A, Tokuoka H, Kikuchi T, Watanabe K, Alev L, Mimura M.

Neuropsychiatr Dis Treat. 2017 Sep 19;13:2437-2445. doi: 10.2147/NDT.S134566. eCollection 2017.

5.

Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine.

Tokuoka H, Nishihara M, Fujikoshi S, Yoshikawa A, Kuga A.

Neuropsychiatr Dis Treat. 2017 Sep 25;13:2457-2467. doi: 10.2147/NDT.S143093. eCollection 2017.

6.

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.

Kuga A, Tsuji T, Hayashi S, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T.

Neuropsychiatr Dis Treat. 2017 Aug 4;13:2115-2124. doi: 10.2147/NDT.S136448. eCollection 2017.

7.

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.

Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T.

Neuropsychiatr Dis Treat. 2017 Aug 4;13:2105-2114. doi: 10.2147/NDT.S131438. eCollection 2017.

8.

Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy.

Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, Akasaka-Manya K, Furukawa JI, Mizuno M, Kawakami H, Shinohara Y, Wada Y, Endo T, Toda T.

Cell Rep. 2016 Mar 8;14(9):2209-2223. doi: 10.1016/j.celrep.2016.02.017. Epub 2016 Feb 25.

9.

Trajectories of depression symptom improvement and associated predictor analysis: An analysis of duloxetine in double-blind placebo-controlled trials.

Tokuoka H, Takahashi H, Ozeki A, Kuga A, Yoshikawa A, Tsuji T, Wohlreich MM.

J Affect Disord. 2016 May 15;196:171-80. doi: 10.1016/j.jad.2016.02.039. Epub 2016 Feb 17.

10.

Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.

Kanagawa M, Yu CC, Ito C, Fukada S, Hozoji-Inada M, Chiyo T, Kuga A, Matsuo M, Sato K, Yamaguchi M, Ito T, Ohtsuka Y, Katanosaka Y, Miyagoe-Suzuki Y, Naruse K, Kobayashi K, Okada T, Takeda S, Toda T.

Hum Mol Genet. 2013 Aug 1;22(15):3003-15. doi: 10.1093/hmg/ddt157. Epub 2013 Apr 4.

PMID:
23562821
11.

Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.

Kuga A, Kanagawa M, Sudo A, Chan YM, Tajiri M, Manya H, Kikkawa Y, Nomizu M, Kobayashi K, Endo T, Lu QL, Wada Y, Toda T.

J Biol Chem. 2012 Mar 16;287(12):9560-7. doi: 10.1074/jbc.M111.271767. Epub 2012 Jan 23.

12.

[Recent Advances in α-dystroglycanopathy].

Kuga A, Kanagawa M, Toda T.

Brain Nerve. 2011 Nov;63(11):1189-95. Review. Japanese.

PMID:
22068471
13.

Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy.

Taniguchi-Ikeda M, Kobayashi K, Kanagawa M, Yu CC, Mori K, Oda T, Kuga A, Kurahashi H, Akman HO, DiMauro S, Kaji R, Yokota T, Takeda S, Toda T.

Nature. 2011 Oct 5;478(7367):127-31. doi: 10.1038/nature10456.

14.

Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice.

Kuga A, Ohsawa Y, Okada T, Kanda F, Kanagawa M, Toda T, Sunada Y.

Hum Mol Genet. 2011 Aug 1;20(15):2975-83. doi: 10.1093/hmg/ddr201. Epub 2011 May 24.

PMID:
21610159
15.

Caveolin-3 regulates myostatin signaling. Mini-review.

Ohsawa Y, Okada T, Kuga A, Hayashi S, Murakami T, Tsuchida K, Noji S, Sunada Y.

Acta Myol. 2008 Jul;27:19-24. Review.

16.

Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression Scale.

Kanda F, Oishi K, Sekiguchi K, Kuga A, Kobessho H, Shirafuji T, Higuchi M, Ishihara H.

Parkinsonism Relat Disord. 2008;14(1):19-23. Epub 2007 Aug 16.

PMID:
17702629
17.

[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].

Kuga A, Oishi K, Ishida H, Kanda F.

Rinsho Shinkeigaku. 2007 May;47(5):207-10. Japanese.

PMID:
17585601
18.

[32 year old male case of paraneoplastic non-herpetic limbic encephalitis with thymoma].

Kuga A, Uesaka Y, Kunimoto M, Nagasaka S, Itami J, Iwamura A, Yuasa T.

Nihon Naika Gakkai Zasshi. 2005 Nov 10;94(11):2385-7. Japanese. No abstract available.

PMID:
16363744
19.

[Posterior spinal cord infarction presenting Brown-Séquard syndrome].

Kuga A, Mitani M, Funakawa I, Jinnai K.

Rinsho Shinkeigaku. 2005 Oct;45(10):730-4. Japanese.

PMID:
16318367
20.

[Allergic skin rashes by methylprednisolone in a case with multiple sclerosis].

Kuga A, Futamura N, Funakawa I, Jinnai K.

Rinsho Shinkeigaku. 2004 Oct;44(10):691-4. Review. Japanese.

PMID:
15568486
21.
22.

[Present situation of drug resistance and future prospects].

Inoue M, Kuga A, Hosaka Y, Kaieda S.

Nihon Rinsho. 2001 Apr;59(4):645-51. Review. Japanese.

PMID:
11304984
23.

Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M.

Antimicrob Agents Chemother. 2001 May;45(5):1343-8.

24.

[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC].

Inoue M, Kuga A, Kaieda S, Hosaka M, Kitasato H, Sato Y, Okamoto R, Eda T, Hoshino K, Seto I.

Jpn J Antibiot. 2000 Sep;53(9):593-608. Japanese.

PMID:
11214999
25.

[Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].

Kuga A, Yano H, Okamoto R, Sato Y, Miyata A, Inoue M.

Jpn J Antibiot. 1999 Sep;52(9):585-94. Japanese.

PMID:
10746193
26.

Presence of genes for beta-lactamases of two different classes on a single plasmid from a clinical isolate of Serratia marcescens.

Yano H, Kuga A, Irinoda K, Okamoto R, Kobayashi T, Inoue M.

J Antibiot (Tokyo). 1999 Dec;52(12):1135-9. No abstract available.

27.

ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae.

Kuga A, Okamoto R, Inoue M.

Antimicrob Agents Chemother. 2000 Mar;44(3):561-7.

28.

Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.

Yano H, Suetake M, Kuga A, Irinoda K, Okamoto R, Kobayashi T, Inoue M.

J Clin Microbiol. 2000 Feb;38(2):625-9.

29.

Why do antimicrobial agents become ineffectual?

Inoue M, Kuga A, Shimauchi C, Yano H, Okamoto R.

Yonsei Med J. 1998 Dec;39(6):502-13. Review.

30.

[Bacterial sensitivity test to formulate an anti-infective strategy].

Inoue M, Kuga A, Yano J, Shimauchi C, Nonoyama K, Okamoto R.

Nihon Naika Gakkai Zasshi. 1998 Nov 10;87(11):2179-84. Japanese. No abstract available.

PMID:
9921198
31.

Detection of tet(K) and tet(M) in Staphylococcus aureus of Asian countries by the polymerase chain reaction.

Warsa UC, Nonoyama M, Ida T, Okamoto R, Okubo T, Shimauchi C, Kuga A, Inoue M.

J Antibiot (Tokyo). 1996 Nov;49(11):1127-32.

32.

[A treated case of renovascular hypertension].

Chabata T, Ishibe T, Kato T, Kuga A.

Hinyokika Kiyo. 1967 Jul;13(7):525-30. Japanese. No abstract available.

Supplemental Content

Support Center